Hyperstimulation of leukocytes by plasma from cardiopulmonary bypass patients is diminished by α-MSH pretreatment

International Journal of Cardiology

Volumn 53, Issue SUPPL., 1996, Pages

  Bilfinger, Thomas V ^a,b   Hughes, Thomas K ^c   Rodriguez, Madeline ^b   Glass, Richard ^b   Casares, Frederico ^b   Stefano, George B ^a,b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alpha MSH; Cardiopulmonary bypass; Granulocytes; Monocytes

Indexed keywords

ALPHA INTERMEDIN; BIOLOGICAL RESPONSE MODIFIER;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRANULOCYTE; HEART DISEASE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; MONOCYTE; PRIORITY JOURNAL;

EID: 0029898405     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02571-5     Document Type: Article

References (45)

1. Allardyce DB, Yoshida SH, Ashmore PG. The importance of microembolism in the pathogenesis of organ dysfunction caused by prolonged use of pump-oxygenator. J Thorac Cardiovasc Surg 1966; 52: 706-714.
2. Blackstone EH, Kirklin JW, Stewart RW, Chenoweth DE. The damaging effects of cardiopulmonary bypass. In: Wu KK, Rossi EC, editors. Prostaglandins in Clinical Medicine: Cardiovascular and Thrombotic Disorders. Chicago: Year Book Medical, 1982: 355-369.
3. Roth J, Golub S, Cukingnan R. Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg 1981; 31: 350.
4. Utley R. The immune response to cardiopulmonary bypass. In: Utley JR, editor. Pathopsychology and Techniques of Cardiopulmonary Bypass. Vol. 1. Baltimore: Williams & Wilkins, 1982; 132-144.
5. Royston D. Blood cell activation. Semin Thorac Cardiopulmon Surg 1990; 2: 341-357.
6. Bilfinger TV, Stefano GB. Evidence of immunocyte stimulatory molecule(s) in plasma of patients undergoing cardiopulmonary bypass. J Cardiovasc Surg 1993; 34: 129-133.
7. Stefano GB, Bilfinger TV. Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: loss of DAME and IL-1 chemotaxis. J Neuroimmunol 1993; 47: 189-198.
8. Kusserow B, Larrow R. Studies of leukocyte response to prolonged blood pumping-effects upon phagocytic capability and total white cell count. Trans Am Soc Artif Intern Organs 1968; 14: 216.
9. Kusserow B, Larrow R, Nichols J. Metabolic and morphological alterations in leukocytes following prolonged blood pumping. Trans Am Soc Artif Intern Organs 1969; 1-5: 40.
10. Kusserow B, Larrow R, Nichols J. Perfusion and surface-induced injury in leukocytes. Fed Proc 1971; 30: 1516.
11. Parker D, Cantrell J, Karp R, Stroud R, Digerness S. Changes in serum complement and immuglobulins following cardiopulmonary bypass. Surgery 1972; 71: 824.
12. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass. N Engl J Med 1981; 304: 497-503.
13. Burrows F, Steele R, Marmer D, Van Devanter S, Westerman G. Influence of operations with cardiopulmonary bypass on polymorphonuclear leukocyte function in infants. J Thorac Cardiovasc Surg 1987; 93: 253-260.
14. Bilfinger TV. Complement activation during extracorporeal circulation. Adv Neuroimmunol 1993; 3: 269-277.
15. Stefano GB, Bilfinger TV, Fricchione GL. The immune-neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 1994; 42: 475-488.
16. Stefano GB, Cadet P, Sinesterra J, Scharrer B. Comparative aspects of the response of human and invertebrate immunocytes to stimulation by opioid neuropeptides. In: Stefano, editor. Comparative aspects of neuropeptide function, Florey, Manchester Univ Press, UK, 1991; 329-334.
17. Duvaux-Miret O, Stefano GB, Smith EM, Dissous C, Capron A. Immunosuppression in the definitive and intermediate host of the human parasite schistosomiasis mansoni by release of immunoactive neuropeptides. Proc Natl Acad Sci USA 1992; 89: 778-781.
18. Smith EM, Huhes TK, Cadet P, Stefano GB. CRF induced immunosuppression in human and invertebrate immunocytes. Cell Mol Neurobiol 1992; 12: 473-482.
19. Downing SW, Edmunds LH. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 1336-43.
20. Shipp MA, Stefano GB, D'Adamio L, Switzer SN, Howard FD, Sinisterra J, Scharrer B, Reinherz E. Down regulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature 1990; 347: 394-396.
21. Stefano GB, Kushnerik V, Rodriquez M, Bilfinger TV. Inhibitory effect of morphine on granulocyte stimulation of tumor necrosis factor and substance P. Int J Immunopharmacol 1994; 16: 329-334.
22. Stefano GB, Cadet P, Scharrer B. Stimulatory effects of opioid neuropeptides on locomotory activity and conformational changes in invertebrate and human immunocytes: evidence for a subtype of delta receptor. Proc Natl Acad Sci USA 1989; 86: 6304-6311.
23. Stefano GB, Leung MK, Zhao X, Scharrer B. Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes. Proc Natl Acad Sci USA 1989; 86: 626-630.
24. Schon JC, Torre-Bueno J, Stefano GB. Microscopic computer assisted analysis of conformational state: reference to neuroimmunology. Adv Neuroimmunol 1991; 1: 252-259.
25. Stefano GB, Melchiorri P, Negri L, Hughes TK, Scharrer B. (D-Ala2)Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and inveretebrate immune cells. Proc Natl Acad Sci USA 1992; 89: 9316-9320.
26. Riddle P, Berenbaum M, Postoperative depression of the lymphocyte response to phytohaemagglutin. Lancet 1967; 1: 746.
27. Park S, Brody J, Wallace H, Blakemore W. Immunosuppressive effect of surgery. Lancet 1971; 1: 53.
28. Hofmann J, Heim L, Boulanger W, DeCosse J. The effect of surgery on cellular immunity. Wis Med J 1973; 72: 249.
29. Roth J, Golub S, Grimm E. Effect of surgery on in vitro lymphocyte function. Surg Forum 1974; 25: 102.
30. Roth J, Golub S, Grimm E. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function. Surgery 1976; 79: 46.
31. Cullen B, Van Belle G. Lymphocyte transformation and changes in leukocyte count: effects of anesthesia and operation, Anesthesiology 1975; 43: 563.
32. Slade M, Simmons R, Yunnis E, Greenberg L. Immunodepression after major surgery in normal patients. Surgery 1975; 78: 363.
33. Lee Y. Effect of anesthesia and surgery on immunity. J Surg Oncol 1977; 9: 425.
34. Ryhanan P, Herva E, Hollmen A, Nuutinen L, Pihlajaniemi R, Saarela E. Changes in peripheral blood leukocyte counts, lymphocyte subpopulations, and in vitro transformation after heart valve replacement. J Thorac Cardiovasc Surg 1979; 77: 1259.
35. Hansbrough J, Bender E, Zapata-Sirvent R. Altered helper and suppressor lymphocyte populations in surgical patients. A measure of postoperative immunosuppression. Am J Surg 1984; 148: 303.
36. Konsgaard UE, Smith-Erichson N, Geiran O, Amundsen E, Mollenes TE, Garred P. Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery. Acta Anaesthesiol Scand 1989; 33: 343-347.
37. Goldstein RE. Involvement of leukocytes and leukotrienes in ischemic dysfunction of the coronary microcirculation. Eur Heart J 1990; 11 Suppl B: 16-26.
38. Mason MJ, Van Epps D. Modulation of IL-1, tumor necrosis factor, and C5a mediated murine neutrophil migration by α-melanocyte stimulating hormone. J Immunology 1989; 142: 1646-51.
39. Catania A, Lipton JM. The neuropeptide alpha-melanocyte-stimulating hormone: a key component of neuroimmunomodulation. Neuroimmunomodulation 1994; 1: 93-99.
40. Ceriani G, Diaz J, Murphree S, Catania A, Lipton JM. The neuropeptide α-melanocyte stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1994; 1: 28-32.
41. Hiltz ME, Catania A, Lipton JM. α-MSH peptides inhibit acute inflammation induced in mice by rIL-1, rIL-6, rTNF-α, and endogenous pyrogen but not that caused by LBT4, PAF, and rIL-8. Cytokine 1992; 4: 320-382.
42. Taylor AV, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992; 11: 1199-1206.
43. Van Epps DE, Mason MM, Modulation of leukocyte migration by α-melanocyte stimulating hormone. In: Stefano, Florey, editor. Comparative Aspects of Neuropeptide Function. Manchester Univ. Press, UK, 1992; 335-345.
44. Bilfinger TV, Fricchione G, Stefano GB. Neuroimmune implications of cardiopulmonary bypass. Adv Neuroimmunol 1993; 3: 277-288.
45. Lipton JM. Neuropeptide alpha-melanocyte stimulating hormone in control of fever, the acute phase response and inflammation. In: Goetzel GJ, Spector NH, editors. Neuroimmune Networks; Physiology and Diseases. New York, Alan R. Liss, 1989; 243-250.